Global Animal Model for Testing Market Strategic Research Report

Scope of the Report

The global Animal Model for Testing market size is predicted to grow from US$ 2,815 million in 2025 to US$ 4,017 million in 2032; it is expected to grow at a CAGR of 5.3% from 2026 to 2032.

Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process. Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans. In our report, all the animals used in scientific purposes are included.

The Animal Model for Testing market is driven by the increasing demand for reliable preclinical data in drug development, biomedical research, and regulatory approval processes. As pharmaceutical and biotechnology companies expand their R&D pipelines, animal models remain essential for evaluating disease mechanisms, therapeutic efficacy, and drug safety before human clinical trials. The rise in chronic and rare diseases, along with advancements in genetic engineering technologies, has led to the development of more precise and disease-specific animal models. Additionally, supportive government funding and collaborations between academia and industry are accelerating the adoption of advanced animal models, particularly in oncology, neurology, and infectious disease research.

Despite their critical role, animal models for testing face several significant challenges, particularly ethical concerns and scientific limitations. Growing pressure from animal welfare organizations and stricter regulatory guidelines are increasing scrutiny around the use of animals in research. Moreover, the high cost and complexity of developing and maintaining genetically modified or disease-specific models limit their accessibility, especially for smaller institutions. Scientific limitations also persist, as animal models do not always accurately predict human responses, leading to potential setbacks in drug development. These challenges are driving the push toward alternative testing methods, such as in vitro systems and computer-based simulations, though these are not yet fully capable of replacing animal models in all research contexts.

Global Animal Model for Testing key players include Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, etc. Global top four manufacturers hold a share about 45%. North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share over 50 percent. In terms of product, Mice is the largest segment, with a share over 60%. And in terms of application, the largest application is Pharmaceutical and Biotechnology Companies, followed by Academic and Research Institutes.

This report presents a comprehensive overview of the global Animal Model for Testing market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Rats
• Mice
• Others

Segment by players, this report covers

• Charles River Laboratories
• Envigo
• Taconic Biosciences
• Jackson Laboratory
• Crown Biosciences
• Shanghai SLAC
• Shangghai Modelorg
• GenOway
• Syngene International
• Psychogenics
• Pharmaron
• Pharmalegacy
• Vitalstar Biotechnology
• JANVIER LABS

Segment by Application

• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Animal Model for Testing market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Academic and Research Institutes, Pharmaceutical and Biotechnology Companies evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact